About Us

SmartDx is a California based LLC that is focused on the development and commercialization of direct-to-consumer genetic testing predictive assessments for cardiac and cancerous diseases in canines. We believe that direct-to-consumer screening for such diseases will soon become one of the pillars of modern personalized veterinary medicine because such high quality disease risk predictions can allow for early and directly relevant preventative care and monitoring of at-risk canines. These assessments can be initiated by the pet owner, breeder, or veterinarian with a simple mouth swab. While we DO provide lifetime disease risk assessments using a simple oral swab of your dog, we DO NOT provide blood draw based risk assessments or early detection.